AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06326632 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Respiratory Re-training
Description: The respiratory re-training lasted for 30 minutes per session and was repeated three times a week for 12 consecutive weeks. The program consisted of diaphragmatic breathing exercises, breath-hold, and breathing control exercises, pursed lip breathing, respiratory muscle strengthening, postural correction exercises, and relaxation techniques.
Study NCT05289349 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propofol
Description: Propofol (2 mg/kg) for induction of anesthesia , and ( 6 mg/kg/h) for maintenance of anesthesia
Study NCT05289349 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sevoflurane
Description: Sevoflurane 1.0-1.5 minimum alveolar concentration (MAC)
Study NCT04123314 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Psilocybin
Description: Dosing at the first session will be 15 mg/70 kg. For the second session participants will either remain at the initial dose, or increase to 25 mg/70 kg at the discretion of the study team.
Study NCT05136404 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Selpercatinib
Description: Administered orally
Study NCT06383117 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Calcium carbonate
Description: 2 capsules containing 600 mg of calcium carbonate each
Study NCT06383117 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Placebo Control
Description: 2 capsules containing methylcellulose
Study NCT06050109 — intervention group
Intervention type: DRUG
Intervention: OFS continues to use group after 5 years use
Description: Patients included in the group continued or discontinued to use goserelin or leuprolide after 5 years use.
Study NCT06050109 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Immunohistochemical detection of HR status
Description: Enrolled patients must be HR-positive premenopausal breast cancer patients
Study NCT03762291 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CVD908ssb-TXSVN
Description: TXSVN may activate the immune system which is the participants body's ability to fight disease, and help develop a response against cancer cells that express Survivin. Survivin has been safely targeted using immune cells, drugs or direct inhibitors in over 50 patients with cancers in published reports.~Survivin belongs to the group of proteins known as tumor-associated antigens (TAAs). These are cell proteins that are specific to the cancer cell. They either are not found or are found in low levels normal cells in the human body. More than 90% of myeloma cancer cells have been shown to possess large quantities of Survivin.
Study NCT05920746 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kinesiotherapy with magnetotherapy
Description: Individual kinesiotherapy. Parameters of magnetic field: 7 mT, f= 10-20 Hz, type of impulse: bipolar, rectangular pulse
Study NCT05101486 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Ad26.RSV.PreF-based Vaccine
Description: Ad26.RSV.PreF-based Vaccine will be administered as single IM injection.
Study NCT06091904 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Remifentanil
Description: Induction: remifentanil TCI 3 ng/ml Maintenance: remifentanil TCI 0.5-5 ng/ml
Study NCT06469177 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pain Coach App
Description: Pain Coach App is a mobile application that offers patients undergoing shoulder, hip and knee arthroplasty surgery preoperative educational tools and questionnaires to provide patient specific details to their surgeons for prescribing purposes as well as post operative pain assessment and medication reminders/tracking, problem troubleshooting and a resource library for further pain management tools and education.
Study NCT05086718 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Endoscopic ear surgery
Description: Endoscopic approach without posterior meatal flap elevation will be employed in the ear with dry chronic suppurative otitis media. Tympanoplasty utilizing composite cartilage-fascia graft will be performed. After three months of time period successful outcome will be taken as closure of air bone gap on pure tone audiometry.
Study NCT05590156 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Conventional Rehabilitation
Description: Conventional treatment for the upper extremity will be applied according to the patient's individual needs. A physiotherapist will apply this method in the clinic for 60 minutes. The duration of treatment is 60x3x8 minutes/day/week. Other methods will be applied in addition to the conventional treatment program.
Study NCT04817150 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Laparoscopic ventral mesh rectopexy
Description: Conventional laparoscopic ventral mesh rectopexy, as first described by D'Hoore
Study NCT04817150 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Laparoscopic ventral mesh rectopexy
Description: Conventional laparoscopic ventral mesh rectopexy, as first described by D'Hoore
Study NCT05472493 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: [18-F]CETO
Description: PET/CT will be performed; Non-contrast CT images will be acquired over the adrenals (slice width, \~3 mm). CETO (\~2.5 MBq/kg; up to 365 MBq +/- 20%) will be administered as a single dose intravenously and dynamic PET images will be acquired from \~0-90 minutes.
Study NCT05090787 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Investigational mDCB00
Description: Investigational intraocular lens replaces the natural lens removed during cataract surgery in both eyes.
Study NCT05090787 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Control DCB00
Description: Control intraocular lens replaces the natural lens removed during cataract surgery in both eyes
Study NCT05722197 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Crisis Response Planning and Lethal Means Safety Counseling
Description: Crisis Response Planning is an efficacious, one-session intervention that increases positive affect, decreases negative affect and psychiatric hospitalizations, and reduces suicide attempts by 76% among Servicemembers
Study NCT05487144 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Learning in a Virtual Environment (LIVE)
Description: Phase 1 of the study will be a one-time meeting, either remote or in-person to complete V.E. training and fill out questionnaires. Phase 2 of the study is the 8 week intervention implementation.Participants will access the V.E. community from their homes on a computer with broadband internet. During the first four weeks of the intervention, participants will be required to come into the V.E. at least once per week for at least one hour. For the last four weeks, V.E. participation is strongly encouraged, but not required. The content in the V.E. will focus on psychosocial health and stroke recovery, and the messaging in the VE will be updated bi-weekly to encourage retention and engagement. Group meetings led by the study PI, a psychologist, or another trained member of the research team at least once a week will be offered. During the intervention period, VE-specific data will be collected continuously. Phase 3, will include a survey and a focus group interview via online platform.
Study NCT06037070 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Platelet Rich Fibrin
Description: PRF will be injected inside the hole that prepared to place dental implant
Study NCT06370390 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: swallowing function training
Description: The group rehabilitation program comprised daily 60-minute sessions, five times per week for a duration of 4 weeks.~The group rehabilitation program included: Rehabilitation oral and facial exercises, Game-based surface electromyographic biofeedback training, Participants experience sharing, Individual direct feeding training
Study NCT06068517 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Closed incision negative pressure wound therapy
Description: After the completion of abdominal surgery and standardised skin closure with staples, ciNPWT will be applied, using a commercially available device.
Study NCT06068517 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Standard dressing
Description: After the completion of abdominal surgery and standardised skin closure with staples, standard dressings will be applied.
Study NCT06203171 — intervention group
Intervention type: OTHER
Intervention: Observational
Description: Routine laboratory parameters requested from patients; Direct lung Radiograph and Electrocardiography results were evaluated and preoperative consultations and recommendations requested from the patients were recorded. Type of anesthesia, operation performed, operation duration, intraoperative blood and fluid losses, intraoperative and postoperative complications that develop within the first 24 hours, additional problems that develop (pain, postoperative nausea and vomiting, hypothermia, change of consciousness, bleeding and unplanned transfer to the intensive care unit). postanesthesia recovery The length of stay in the room, length of hospital stay, and method of discharge were recorded. The effects of preoperative laboratory, imaging methods and required consultations on intraoperative and postoperative complications in the first 24 hours were evaluated.
Study NCT04797078 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transperineal biopsy
Description: Transperineal free hand MRI-US fusion prostate biopsy
Study NCT04797078 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Transrectal biopsy
Description: Transrectal MRI-US fusion prostate biopsy
Study NCT05310838 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral Activation for First Episode Psychosis
Description: Sessions will be offered weekly and dyads can complete the intervention during a 6-month period to accommodate competing demands encountered by the population.
Study NCT05310838 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Treatment As Usual
Description: Given this condition, patients may also receive individual rehabilitation and/or group psychosocial interventions as part of typical clinic care.
Study NCT05812469 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brain Awareness Intervention
Description: effect of brain awareness intervention on metacognition, self-efficacy and treatment motivation in patients with alcohol and substance use disorders
Study NCT05812469 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Being Healthy Education
Description: This training included trainings on Healthy Nutrition, Sexually Transmitted Diseases, Importance of Physical Activity and Personal Hygiene prepared by the researcher in the form of presentations for the patients in the control group.
Study NCT05579652 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Abdominal tension measurement
Description: A tensiometer scale will be used to measure the tension needed to pull each side of the abdominal wall to midline
Study NCT06102811 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low Concentration Local Anesthetic Fascia Iliaca Compartment Block
Description: Fascia iliaca block with Ropivacaine 0.075% (50 mL)
Study NCT06102811 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: High Concentration Local Anesthetic Fascia Iliaca Compartment Block
Description: Fascia iliaca block with Ropivacaine 0.25% (50 mL)
Study NCT05590156 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Robotic Rehabilitation (ExoRehab X)
Description: Robotic Rehabilitation
Study NCT05590156 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Action Observation Therapy (AOT)
Description: Action Observation Therapy (AOT)
Study NCT04904159 — intervention group
Intervention type: PROCEDURE
Intervention: Thyroidectomy
Description: total thyroidectomy
Study NCT04904159 — intervention group
Intervention type: PROCEDURE
Intervention: Lobectomy
Description: Lobectomy
Study NCT05605041 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Headspace
Description: Headspace is an app that allows users to practice mindfulness through guided meditation
Study NCT04614116 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: External cooling
Description: water-circulating cooling/warming sleeves connected to a medical cooling device (Hilotherm Clinic®, Hilotherm GmbH, Germany) will be placed around the subject's abdomen and lower back. Initially the temperature of the water will be set to 25°C. A mild cold stimulus will be applied by reducing the temperature of the circulating water by approximately 1°C every 2 minutes to a minimum of 10°C.
Study NCT04614116 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: FDG PET/CT
Description: o 75 MBq 18F-FDG will be injected through the intravenous line on the scanner manually (bolus injection) with a simultaneous start of dynamic FDG-PET/CT scan for 45 minutes and a partial body scan from head to the abdomen after 45 minutes. Total scan time 60 minutes.
Study NCT04614116 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: 13C-Glucose injection
Description: 0.5 g 13C-Glucose i.v. infusion over 5 minutes, after termination of FDG injection
Study NCT06273085 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Patient education
Description: 3 sessions of education over phone at 1, 3 and 5 months after discharge, each session includes an overview of benefits and side effects of GDMT, inquiries about reasons of not using optimal doses of GDMT medications, and encouraging adherence to visits with providers.
Study NCT06314009 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: functional Magnetic Resonance Imaging (fMRI)
Description: Participants will undergo a functional Magnetic Resonance Imaging (fMRI) using arterial spin labeling (ASL) and other Magnetic Resonance (MR) sequences
Study NCT05246176 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: nephrostomy set
Description: insertion of the nephrostomy set through the skin to obtaining good external drainage of bile in case of malignant obstructive jaundice.
Study NCT04711967 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Fecal Microbiota Transplantation
Description: fecal microbiota transplantation
Study NCT04711967 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: drug
Description: drug
Study NCT05012865 — intervention group
Intervention type: DRUG
Intervention: avelumab
Description: as provided in real world practice
Study NCT05012865 — intervention group
Intervention type: DRUG
Intervention: axitinib
Description: as provided in real world practice
Study NCT04882865 — intervention group
Intervention type: DEVICE
Intervention: assist
Description: A custom designed patient wrap will envelope the patient. This will be coupled to a mechanical lift system to facilitate repositioning of the patient (AMMP) Commercially available repositioning sheets will be used for the general care of some study patients
Study NCT04961099 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HY01
Description: low-dose group: HY01 10mg（20mg/ml）, administrated on D1, D4 and D7 high-dose group: HY01 20mg（40mg/ml）, administrated on D1, D4 and D7
Study NCT06248905 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rehabilitation program based on the strengthening of gluteal muscles
Description: Physiotherapy program (8 weeks)
Study NCT05623631 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Survey
Description: Surveys were distributed using REDCap, and participants were asked to complete these within 5 weeks of receiving the invitation.
Study NCT06248905 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy
Description: Focused shock wave therapy (3 weeks)
Study NCT06248905 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Extracorporeal shock wave therapy
Description: Focused shock wave therapy (3 weeks)
Study NCT05372588 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NVX-CoV2515
Description: Intramuscular (deltoid) injection of co-formulated Omicron BA.1 SARS-CoV-2 rS vaccine with Matrix-M adjuvant (0.5 mL).
Study NCT05405036 — intervention group
Intervention type: OTHER
Intervention: simulated patient
Description: In the last month of the Measurement and Evaluation course in Physiotherapy, a simulated patient session will be held four times (with disease in the cervical-lumbar-shoulder and knee region). Students will be evaluated by the methods they learned about patients. 10 days before and after the simulated patient sessions, the questionnaire will be applied in Turkish for validity and reliability, and then the questionnaire will be repeated after the simulated patient sessions are over, and the effect of the smile patient sessions on the perceived communication skills of the patient will be examined.
Study NCT04586244 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: retifanlimab
Description: retifanlimab will be administered via IV over 30 minutes (+ 15 min) on Day 1 of each 28-day cycle, up to 3 cycles,
Study NCT04586244 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: epacadostat
Description: epacadostat will be administered daily twice daily orally up to and including day of surgery.
Study NCT04586244 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INCAGN02385
Description: INCAGN02385 will be administered via IV over 30 minutes (-5/+10 min) every 2 weeks.
Study NCT05372588 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NVX-Cov2373
Description: Intramuscular (deltoid) injection of co-formulated prototype SARS-CoV-2 rS vaccine with Matrix-M adjuvant(0.5 mL).
Study NCT05372588 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NVX-CoV2373 + NVX-CoV2515
Description: Intramuscular (deltoid) injection of 5 µg total (2.5 µg NVX-CoV2373 + 2.5 µg NVX-CoV2515) with 50 µg Matrix-M adjuvant.
Study NCT05372588 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NVX-CoV2540
Description: Intramuscular (deltoid) injection of co-formulated prototype SARS-CoV-2 rS vaccine with Matrix-M adjuvant(0.5 mL).
Study NCT05440630 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Probiotics
Description: Participants in this arm will receive a daily dose of 1x10\^10 Colony Forming Unit (CFU) of a single strain probiotic (live bacteria) for 16 weeks.
Study NCT05372588 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NVX-CoV2373 + NVX-CoV2540
Description: Intramuscular (deltoid) injection of 5 µg total (2.5 µg NVX-CoV2373 + 2.5 µg NVX-CoV2515) with 50 µg Matrix-M adjuvant.
Study NCT04958343 — intervention group
Intervention type: PROCEDURE
Intervention: pelvic reconstruction
Description: After radical cystectomy, the pelvic reconstruction including the ligation of dorsal vascular complex and posterior reconstruction will be performed on patients.
Study NCT05440630 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Postbiotic
Description: Participants in this arm will receive a daily dose of 1x10\^10 Colony Forming Unit (CFU) of a single strain postbiotic (Heat treated bacteria) for 16 weeks.
Study NCT05440630 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants in this arm will receive an equivalent placebo for 16 weeks.
Study NCT05660031 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: LHB Tenotomy
Description: Will be performed arthroscopically by cutting the LHB at its origin with arthroscopic scissors
Study NCT05660031 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: LHB Tenodesis
Description: ill be performed arthroscopically with a tenodesis at the top of the articular margin using an onlay technique.
Study NCT05858073 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Kinesio Taping
Description: Standard 5 cm Kinesio Tex will be used. Initially, a Y-strip was paper-off (without tension) from the starting point to the insertion of the supraspinatus, while the participants were reaching with their upper extremities behind their backs and flexing their necks to the contralateral side. Second, an I-strip from the coracoid process will be applied around the posterior deltoid using approximately 50% to 75% downward flexion. Initially, the shoulder will be externally rotated without elevation, and then slightly horizontally adduction and forward elevation as the end of the band is applied without stretching. This I strip is shaped like a Y at the end of the tape.~Finally, a Y-strip will be applied using paper-off tension from the T10-T12 region to the medial border of the scapula to facilitate the lower trapezius muscle. For this technique, the shoulder was adducted horizontally and the middle tail was applied with the hands crossed over the chest.
Study NCT05858073 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Kinesio Taping
Description: Standard placebo taping will be applied to the placebo Kinesio taping group with a standard 5 cm Kinesio Tex. Two tension-free strips will be applied separately to the acromioclavicular joint and lower trapezius muscle. Suspicious participants will be excluded from the study.
Study NCT06242041 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: sodium zirconium cyclic silicate
Description: On the non-dialysis day, the drug was given to patients in the treatment group, four times a week, starting from 5g/day each time, and the blood potassium before dialysis was maintained at 4.0-5.0mmol/L, which could be adjusted at 10g/week each time, and the highest dose could be increased to 80g/ week.
Study NCT06242041 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: sodium zirconium cyclic silicate
Description: On the non-dialysis day, the drug was given to patients in the treatment group, four times a week, starting from 5g/day each time, and the blood potassium before dialysis was maintained at 4.0-5.0mmol/L, which could be adjusted at 10g/week each time, and the highest dose could be increased to 80g/ week.